VRDN — Viridian Therapeutics, Inc.\DE
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1590750 ·
Last close
$30.06
Market Cap
$3.41B
52W High
$34.29
52W Low
$13.18
ADV30
2,650,719
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 25,752,000 | 24,225,000 | -103,477,000 | -101,209,000 | 1,028,670,000 | 172,860,000 | 447,972,000 |
| Jun 2026 | 284,000 | — | -126,268,000 | -127,119,000 | 1,097,233,000 | 164,986,000 | 435,136,000 |
| Mar 2026 | 141,000 | — | -116,169,000 | -104,901,000 | 789,017,000 | 176,346,000 | 153,009,000 |
| Dec 2025 | 132,000 | — | -122,749,000 | -120,355,000 | 899,418,000 | 212,382,000 | 177,251,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-341,505,000
Investing CF
$-468,979,000
Financing CF
$814,997,000
CapEx
$-11,939,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.84
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,671,687,000
Inventory
$85,000
Receivables
$29,782,000
ST Investments
$782,346,000
EBIT TTM
$-429,260,000
Pretax Income TTM
$-453,584,000
Interest Exp TTM
$24,324,000
Analysts
15
Yahoo Snapshot (yfinance, live)
Total Revenue
$26,309,000
EBITDA
$-467,961,984
Free Cash Flow
$-217,390,880
Enterprise Value
$2,623,595,264
Total Cash
$955,206,016
Total Debt
$245,496,992
Shares Out
113,558,449
Trailing EPS
$-3.85
Book Value
$4.25
ROE
-83.7%
ROA
-36.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 70,849,000 | -363,395,000 | -342,601,000 | 899,418,000 | 177,251,000 | 722,167,000 | -276,391,000 |
| Dec 2024 | 302,000 | -299,035,000 | -269,949,000 | 742,403,000 | 70,764,000 | 671,639,000 | -232,319,000 |
| Dec 2023 | 314,000 | -254,450,000 | -237,734,000 | 490,424,000 | 48,402,000 | 442,022,000 | -184,170,000 |
| Dec 2022 | 1,772,000 | -134,304,000 | -129,874,000 | 435,091,000 | 40,027,000 | 395,064,000 | -93,838,000 |
TTM Snapshot
Revenues TTM
$71,127,000
NetIncome TTM
$-386,974,000
OpCashFlow TTM
—
Assets (Latest)
$1,097,233,000
Forward EPS
$-2.29
Max Pain — expiry 2027-01-15
max pain strike: $20.00 · spot: $30.12 · call oi: 1,028 · put oi: 366
Expected Move to 2027-01-15:
±$5.95
(19.75%) —
implied range
$24.17 –
$36.07
· ATM straddle on $30.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | $3.43B | $26.88 | — |
| ELVN | Enliven Therapeutics, Inc. | $3.45B | $46.85 | — |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.46B | $27.33 | — |
| IRON | Disc Medicine, Inc. | $3.49B | $76.57 | — |
| PBLS | Parabilis Medicines, Inc. | $3.49B | $28.25 | — |
News headlines (Yahoo Finance, 1h cache)
Viridian Therapeutics gains long-term potential from extended-acting FcRn drug, Jefferies says
2026-11-09 20:06 · Yahoo
Viridian Therapeutics Announces Positive VRDN-008 Phase 1 Results Supporting Potential Best-in-Class Profile with Every-8-Week Subcutaneous Dosing
2026-11-09 12:01 · Yahoo
Viridian Therapeutics to Host Conference Call to Present VRDN-008 Phase 1 Data and FcRn Portfolio Plans on November 9, 2026
2026-11-06 21:01 · Yahoo
Wall Street Analysts Predict a 39.68% Upside in Viridian Therapeutics (VRDN): Here's What You Should Know
2026-11-06 13:55 · Yahoo
Viridian Therapeutics, Inc. Q3 2026 Earnings Call Summary
2026-11-05 01:41 · Yahoo
Viridian Therapeutics (VRDN) Stock Looks Overvalued Even With Its New Launch
2026-11-05 01:09 · Yahoo
What Viridian Therapeutics (VRDN) Said on Its Q3 Earnings Call
2026-11-04 22:14 · Yahoo
Viridian (VRDN) Q3 2026 Earnings Call Transcript
2026-11-04 19:45 · Yahoo
Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Beats Revenue Estimates
2026-11-04 12:55 · Yahoo
Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
2026-11-04 12:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.